AMY HUFF: Open Payments
NPI 1669642088 · TYLER, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,008 in 24 payments from 12 companies in 2025. Trend: 2023 $290 · 2024 $378 · 2025 $1,008
Food & beverage: $1,008
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 2 | $190 |
| Forte Bio-Pharma LLC | 1 | $125 |
| Madrigal Pharmaceuticals | 1 | $109 |
| AstraZeneca Pharmaceuticals LP | 6 | $105 |
| Teva Pharmaceuticals USA, Inc. | 1 | $105 |
| SANOFI-AVENTIS U.S. LLC | 1 | $103 |
| ABBVIE INC. | 6 | $101 |
| Paratek Pharmaceuticals, Inc. | 1 | $79 |
| Novo Nordisk Inc | 2 | $35 |
| Otsuka America Pharmaceutical, Inc. | 1 | $28 |
Products named: PROLATE, KRYSTEXXA, REZDIFFRA, AUSTEDO XR, TZIELD, NUZYRA, VRAYLAR, AIRSUPRA.
Industry payments across TX — which companies pay providers there.
